Company intelligence / Profile preview

Symatese

Chaponost, Auvergne-Rhône-Alpes, Francesymatese.com ↗
Ownership
Private
Employees
~415
Development stage
Commercial
01

Overview

Symatese is a leading French private company specializing in the design, development, and manufacture of innovative medical devices based on biopolymers such as collagen and hyaluronic acid. Its products are used globally across more than 15 therapeutic areas for tissue regeneration, reconstruction, wound healing, aesthetics/cosmetics, surgical implants/devices. The company partners with major global healthcare brands; its technologies reach over 25 million patients annually. It is recognized for scientific excellence in tissue engineering with strong R&D investment (~10–15% of annual revenue).

Therapeutic areas
Men's HealthOtherDermatologyRheumatologyCardiovascularOphthalmologyNeurology
Modalities
DeviceBiologicCollagen-based biomaterialHyaluronic acid-based biomaterialSilicone-based implantable deviceThermoplastic medical device component
Industry
Implantable Medical Devices
02

Drug pipeline

2 assets

ESTYME

Commercial
Indications
Facial rejuvenation

1 more asset in the full pipeline.

Request access →
03

Partnerships

L’Oréal/Episkin (cosmetic tissue models)Johnson & JohnsonGaldermaEvolus Inc.Biotech Dental Group BVI Medical DevicesURGOMedtronVygon

Beyond the preview

Go deeper on Symatese.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Symatese.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call